Gavin Bennett

Gavin Bennett

Company: Bicycle Therapeutics

Job title: Senior Director - Drug Development


Bicycle Conjugates to Target Solid Tumours 4:30 pm

Bicycles, constrained bicyclic peptides, offer antibody-like affinity and selectivity in a small molecule format Bicycle Toxin Conjugates are now in clinical development, offering rapid tumour penetration with limited plasma exposure Discover how Bicycles can be used to stimulate Immuno-oncology targets such as CD137, which can be targeted to tumour cells using Bicycle tumour-targeted immune cell…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.